Australia Health

Botanix Pharmaceuticals (ASX:BOT) generated $10.1 million in net revenue for the fourth quarter of fiscal 2026.

Imugene (ASX:IMU) CEO Leslie Chong has stepped down after nearly 11 years of service.

Imricor Medical Systems (ASX:IMR) launched its commercial rollout in the United States after securing its first hospital customer.

Radiopharm Theranostics (ASX:RAD) secured $12.5 million in fresh capital through an institutional raising.

EBR Systems (ASX:EBR) released a statement addressing online speculation after two patients implanted with its WiSE system.

Resonance Health (ASX:RHT) generated $14.3 million in cash receipts for FY26 while maintaining positive operating cash flow each quarter.

Little Green Pharma (ASX:LGP) CFO Paula Butler has tendered her resignation, effective July 31.

Austco Healthcare (ASX:AHC) secured a $4.2 million maintenance contract for the Jurong Health Complex in Singapore.

Alcidion Group (ASX:ALC) reported a record positive operating cash flow of $24.6 million in cash receipts.

Clinuvel Pharmaceuticals (ASX:CUV) will relocate its corporate headquarters to the U.S. by Jan. 1, 2027 and reduce its global workforce by 10% to 20%.

Dimerix (ASX:DXB) secured a United States patent for its drug candidate DMX-652 through 2043.

Medical technology company PolyNovo (ASX:PNV) reported a 16.1% rise in annual group revenue to $150 million for FY26.